Skip to main content
Equibles

IPHA · Innate Pharma SA · Earnings Call Transcripts & Audio

Track IPHA — free

Use IPHA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IPHA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.63 +0.03 (+1.88%) At close · Sep 30
Rebalance outlook locked
Market Cap
$189.89M
Shares
111.70M
Volume · Sep 30 37.81K Avg daily vol (3M) 151.12K

Innate Pharma SA Earnings Call Transcripts

Quarterly earnings calls for Innate Pharma SA (IPHA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-14
Innate Pharma SA (IPHA) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-14
Innate Pharma SA (IPHA) Q2 2026 Earnings Call
Confident tone IPH4502 Nectin-4 ADC Monalizumab / Pacific 9 ADC preclinical portfolio
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Innate Pharma SA (IPHA) Q1 2026 Earnings Call Transcript
Confident tone Catalysts and upcoming milestones Monalizumab / Pacific 9 Phase 3 NSCLC AstraZeneca collaboration economics
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Innate Pharma SA (IPHA) Q4 2025 Earnings Call Transcript
Positive tone IPH 4502 Nectin-4 ADC Lacutamab / CTCL development and financing Monalizumab / AstraZeneca partnership
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Innate Pharma SA (IPHA) Q3 2025 Earnings Call Transcript
Confident tone IPH4502 ADC Monalizumab PACIFIC-9 Regulatory milestones and FDA interaction
Results not yet reported
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2025-09-25
Innate Pharma SA (IPHA) September 2025 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-06-26
Innate Pharma SA (IPHA) Q2 2025 Earnings Call Transcript
Positive tone Lacutamab Phase III Plans and Partnering IPH4502 Nectin-4 ADC Differentiation and Opportunity IPH4502 Phase I Clinical Progress and Milestones
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Innate Pharma SA (IPHA) Q1 2025 Earnings Call Transcript
Positive tone ADC programs ANKET NK-Cell Engager platform Lacutamab partnership and development
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Innate Pharma SA (IPHA) Q3 2024 Earnings Call Transcript
Positive tone IPH4502 Nectin-4 ADC ANKET NK cell engager platform Partnership and licensing strategy
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-25
Innate Pharma SA (IPHA) Q2 2024 Earnings Call Transcript
Balanced tone Lacutamab / TELLOMAK in CTCL IPH45 / Nectin-4 ADC Partnerships (Sanofi, AstraZeneca, Takeda)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Innate Pharma SA (IPHA) Q1 2024 Earnings Call Transcript
Balanced tone ADC pipeline expansion ANKET NK cell engager platform AstraZeneca partnership and monalizumab
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Innate Pharma SA (IPHA) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Innate Pharma SA (IPHA) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-28
Innate Pharma SA (IPHA) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Innate Pharma SA (IPHA) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Innate Pharma SA (IPHA) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-24
Innate Pharma SA (IPHA) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Innate Pharma SA (IPHA) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Innate Pharma SA (IPHA) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-23
Innate Pharma SA (IPHA) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Innate Pharma SA (IPHA) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 1 filings 1 filers Visit website Investor relations